Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...

Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

Week 6 NFL action is complete. We are about a third of the way through the season, so we have a considerable sample size to ...

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

A special needs child from HD Kote Taluk underwent successful bilateral cataract surgery, restoring sight and hope, thanks to ...

The fifth annual Optegra Eye Sciences & Zeiss symposium, entitled Hands-on with latest innovations in ophthalmology, took ...

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

The Lopez-led Asian Eye Institute announced Monday that two of its most accomplished doctors were recognized by top ...

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...